Willingness-to-pay and patient-defined benefits in the treatment of hyperhidrosis: results from the first German health services research study in hyperhidrosis
Funding sources: this project was supported by a research grant from Riemser Arzneimittel AG.
Conflicts of interest: C.M. is an employee of Riemser Arzneimittel AG. M.A. is licence holder of the Patient Benefit Index. He has received honoraria for participation in advisory boards and consulting activities from Riemser Arzneimittel AG.
No abstract is available for this article.